Loading...

MLL(11Q23) GENE REARRANGEMENT (ALL/AML), HEPARIN BLOOD

image not found

 NABL Cap Accredited 
The MLL (11q23) Gene Rearrangement test at Metropolis Healthcare is a specialized molecular and cytogenetic analysis used to detect abnormalities in the MLL gene region. These rearrangements are clinically significant in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML), helping in diagnosis, prognosis, and treatment planning. This test is essential for identifying high-risk disease patterns and guiding targeted therapeutic decisions. Metropolis Healthcare performs this analysis using advanced FISH or molecular techniques on heparinized blood samples, ensuring precise and dependable results

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 4,345.00

Sample Type: HEPARIN BLOOD

Fasting Not Required


Notes:T0008

Frequently Asked Questions (FAQ's):

 What does the MLL (11q23) Gene Rearrangement test include?

Metropolis Healthcare evaluates the MLL gene region to identify chromosomal translocations or rearrangements associated with ALL and AML.

How does Metropolis Healthcare perform this test?
The analysis is carried out using specialized FISH or molecular diagnostic methods on heparin blood samples for accurate detection.

Who should undergo this test?
Patients diagnosed with or suspected of having ALL or AML may require this test for risk assessment at Metropolis Healthcare.

Is any preparation needed before the test at Metropolis Healthcare?
No fasting or special preparation is required for giving a heparin blood sample.

How long do results take at Metropolis Healthcare?
Results typically take 5–7 days due to the complexity of cytogenetic and molecular processing.

How does this test help doctors?
Metropolis Healthcare provides detailed genetic information that assists clinicians in determining prognosis and planning treatment strategies.

Is this test useful for monitoring disease progression?
Yes, it may be used in follow-up to assess residual disease or treatment response when recommended by a doctor at Metropolis Healthcare.

Are the results reliable?
Metropolis Healthcare follows stringent quality standards and uses advanced genetic platforms to ensure highly accurate findings

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab